A Column to Read
Before You Consult

This episode organizes why the accident reports caused concern, how to separate cell therapy from exosome-based approaches, what to check in the clinic’s management, and which questions matter before you consult.

This episode explains the differences among stem cells, exosomes, and conditioned medium, and helps readers avoid treating regenerative medicine as one single category.

This episode explains why exosomes are often described as safer than cell therapy, what that claim really means, and which checkpoints still matter before you decide where to consult.

This episode gently organizes the points to check before consultation, including strong wording, the actual treatment content, physician involvement, pre-treatment evaluation, and quality control.